首頁 > 市場調查報告書 > 醫療設備

美容整形

亞太地區肉毒桿菌毒素市場預測至 2031 年 - 區域分析 - 按產品（肉毒桿菌毒素 A 和肉毒毒素 B）、應用（醫療和美容）和最終用戶（專科和皮膚科診所、醫院和診所等）

市場調查報告書

商品編碼

1592655

亞太地區肉毒桿菌毒素市場預測至 2031 年 - 區域分析 - 按產品（肉毒桿菌毒素 A 和肉毒毒素 B）、應用（醫療和美容）和最終用戶（專科和皮膚科診所、醫院和診所等）

Asia Pacific Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product (Botulinum Toxin A and Botulinum Toxin B), Application (Medical and Aesthetic), and End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others)

出版日期: 2024年09月16日 | 出版商:

The Insight Partners | 英文 81 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023年亞太肉毒桿菌毒素市場估值為9.2529億美元，預計2031年將達27.4318億美元；預計2023年至2031年複合年成長率為14.6%。

擴大使用肉毒桿菌毒素來增強臉部美觀，推動亞太地區肉毒桿菌毒素市場的發展

整容手術和注射肉毒桿菌是最受歡迎的非侵入性年輕化手術之一。據 ISAPS 稱，2020 年，肉毒桿菌毒素治療是全球領先的非侵入性美容手術。此外，使用A型肉毒桿菌毒素（BoNTA）進行臉部美容治療，以改善上下臉的美觀。在過去的十年中，臉部年輕化手術比不同類型的傳統手術更受歡迎。根據 ISAPS 的數據，2020 年全球進行了約 730 萬例肉毒桿菌手術。

亞太地區肉毒桿菌毒素市場概況

亞太地區肉毒桿菌毒素市場分為中國、印度、日本、韓國、澳洲和亞太其他地區。患有頭痛或偏頭痛的人數每年都在增加，肉毒桿菌毒素已被證明可以有效降低慢性偏頭痛患者頭痛的頻率和嚴重程度。此外，人們對美容手術（例如嫩膚以提高美學吸引力）的認知不斷提高，以及醫療保健支出的增加，有助於推動該地區肉毒桿菌毒素市場的成長。日本的美容產業在過去經歷了巨大的成長。該行業十分發達，可以接觸到各種各樣的美容產品。該行業受到嚴格監管，因此只有持有執照的醫生才能進行美容手術。該國市場的主要推動力是越來越多的消費者願意投資改變和維護自己的外表。根據 ISAPS 的數據，2021 年，全國共進行了 458,749 例肉毒桿菌手術。該國在全球進行非手術美容手術的國家中排名第三，佔全球進行的手術總數的6.3%。

多家國際公司的治療肌肉痙攣的產品已獲得批准。因此，日本企業採取了策略性措施來確保自己的市場地位。 2021 年 6 月，帝人製藥有限公司和 Merz 集團旗下企業 Merz Therapeutics 共同宣布，帝人製藥已獲得日本厚生勞動省 (MHLW) 的額外批准，可銷售 Xeomin（incobotulinumtoxinA）。為了治療下肢痙攣，Xeomin將以50、100或200單位的肌肉注射形式使用。這項策略性舉措使兩家公司都受益，因為 Xeomin 在日本成功推出了治療痙攣的藥物。因此，此類事件預計將鼓勵更多企業開發針對不同醫療狀況的肉毒桿菌進入日本市場。

亞太地區肉毒桿菌毒素市場收入及 2031 年預測（百萬美元）

亞太地區肉毒毒素市場區隔

亞太地區肉毒桿菌毒素市場按產品、應用、最終用戶和國家分類。

根據產品，亞太肉毒桿菌毒素市場分為A型肉毒桿菌毒素和B型肉毒桿菌毒素。。

在應用方面，亞太肉毒桿菌毒素市場分為醫療和美容。 2023年，醫療領域在亞太肉毒桿菌毒素市場中佔據較大佔有率。此外，美觀部分也細分為皺眉紋/眉間紋、額頭紋、魚尾紋、方下巴/咬肌等。

依最終用戶分類，亞太地區肉毒桿菌毒素市場分為專科和皮膚科診所、醫院和診所等。 2023年，專科診所和皮膚科診所佔據亞太地區肉毒桿菌市場的最大佔有率。

依國家/地區分類，亞太地區肉毒桿菌市場分為日本、中國、印度、韓國、澳洲和亞太地區其他地區。 2023年，日本在亞太地區肉毒桿菌素市場佔有率中佔據主導地位。

Merz Pharma GmbH & Co KGaA、AbbVie Inc、Ipsen SA、Evolus Inc、Meditox Inc、Galderma SA、Hugel Inc 和蘭州生物製品研究所有限公司是亞太肉毒桿菌毒素市場上的一些領先公司。

Cosmetic surgery and injectable botulinum toxin are among the most popular noninvasive rejuvenation procedures. According to the ISAPS, in 2020, the botulinum toxin treatment was the leading noninvasive cosmetic procedure performed worldwide. Moreover, the use of botulinum toxin type A-based (BoNTA) cosmetic facial treatments are performed to improve the aesthetics of the upper and lower face. In the last decade, a facial rejuvenation procedure has gained significant popularity over different types of traditional surgeries. According to the ISAPS, ~7.3 million botulinum toxin procedures were performed globally in 2020. Thus, the surge in the adoption of botulinum toxin in facial aesthetic procedures for both men and women from all age groups is driving the botulinum toxin market growth.

Asia Pacific Botulinum Toxin Market Overview

The Asia Pacific botulinum toxin market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The number of people suffering from headache or migraine has been rising every year, and botulinum toxin has been proven effective in reducing the frequency and severity of headaches in patients with chronic migraine. Moreover, the rising awareness of cosmetic procedures such as skin rejuvenation to improve aesthetic appeal and an increase in healthcare expenditure help to boost the growth of the botulinum toxin market in the region. The aesthetic industry in Japan has witnessed massive growth in the past. The industry is well-developed and has access to a wide range of aesthetic products. The industry is highly regulated, and hence, only licensed medical doctors perform aesthetic procedures. The market in the country is mainly driven by the increasing number of consumers willing to invest in altering and maintaining their looks. According to the ISAPS, in 2021, 458,749 botulinum toxin procedures were performed across the country. The country ranks 3rd among all the countries performing nonsurgical aesthetic procedures in the world, with share of 6.3% of the total procedures performed in the world.

Various international companies have obtained approvals for their products that treat muscle spasticity. Thus, Japanese firms have taken strategic initiatives to secure their positions in the market. In June 2021, Teijin Pharma Limited and Merz Therapeutics, a business of the Merz Group, together announced that Teijin Pharma had been granted additional approval by Japan's Ministry of Health, Labor and Welfare (MHLW) to market Xeomin (incobotulinumtoxinA). To treat lower limb spasticity, Xeomin would be used in the form of intramuscular injection in 50, 100, or 200 units. This strategic move has benefited both companies for the successful launch of Xeomin to treat spasticity indication in Japan. Thus, such instances are expected to encourage more players to develop botulinum toxin for different medical conditions to enter the Japanese market.

Asia Pacific Botulinum Toxin Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Botulinum Toxin Market Segmentation

The Asia Pacific botulinum toxin market is categorized into product, application, end user, and country.

Based on product, the Asia Pacific botulinum toxin market is bifurcated into botulinum toxin A and botulinum toxin B. The botulinum toxin A segment held a larger share of Asia Pacific botulinum toxin market share in 2023.

In terms of application, the Asia Pacific botulinum toxin market is bifurcated into medical and aesthetic. The medical segment held a larger share of Asia Pacific botulinum toxin market in 2023. Furthermore, the medical segment is subcategorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. Additionally, the aesthetic segment is subcategorized into frown lines/ glabellar, forehead lines, crow's feet, square jaw/ masseter, and others.

By end user, the Asia Pacific botulinum toxin market is divided into specialty & dermatology clinics, hospitals & clinics, and others. The specialty and dermatology clinics segment held the largest share of Asia Pacific botulinum toxin market in 2023.

Based on country, the Asia Pacific botulinum toxin market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Japan dominated the Asia Pacific botulinum toxin market share in 2023.

Merz Pharma GmbH & Co KGaA, AbbVie Inc, Ipsen SA, Evolus Inc, Medytox Inc, Galderma SA, Hugel Inc, and Lanzhou Institute of Biological Products Co Ltd are some of the leading companies operating in the Asia Pacific botulinum toxin market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Botulinum Toxin Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Popularity of Noninvasive Aesthetics Procedures
- 4.1.2 Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics
4.2 Market Restraints
- 4.2.1 Side Effects of Botulinum Toxin
4.3 Market Opportunities
- 4.3.1 Rising Adoption of Aesthetic Procedure in Emerging Economies
4.4 Future Trends
- 4.4.1 Expanding Therapeutic Applications
4.5 Impact of Drivers and Restraints:

5. Botulinum Toxin Market - Asia Pacific Analysis

5.1 Overview
5.2 Botulinum Toxin Market Revenue (US$ Million), 2021-2031

6. Asia Pacific Botulinum Toxin Market Analysis - by Product

6.1 Overview
6.2 Botulinum Toxin A
- 6.2.1 Overview
- 6.2.2 Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Botulinum Toxin B
- 6.3.1 Overview
- 6.3.2 Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Botulinum Toxin Market Analysis - by Application

7.1 Overview
7.2 Medical
- 7.2.1 Overview
- 7.2.2 Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.2.2.1 Asia Pacific Botulinum Toxin Market Breakdown, by Medical
7.3 Aesthetic
- 7.3.1 Overview
- 7.3.2 Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.3.2.1 Asia Pacific Botulinum Toxin Market Breakdown, by Aesthetic

8. Asia Pacific Botulinum Toxin Market Analysis - by End User

8.1 Overview
8.2 Specialty and Dermatology Clinics
- 8.2.1 Overview
- 8.2.2 Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Hospitals and Clinics
- 8.3.1 Overview
- 8.3.2 Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Botulinum Toxin Market - Country Analysis

9.1 Asia Pacific: Botulinum Toxin Market
- 9.1.1 Asia Pacific: Botulinum Toxin Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 Japan
    - 9.1.1.1.1 Overview
    - 9.1.1.1.2 Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.1.3 Japan: Botulinum Toxin Market Breakdown, by Product
    - 9.1.1.1.4 Japan: Botulinum Toxin Market Breakdown, by Application
    - 9.1.1.1.4.1 Japan: Botulinum Toxin Market Breakdown, by Medical
    - 9.1.1.1.4.2 Japan: Botulinum Toxin Market Breakdown, by Aesthetic
    - 9.1.1.1.5 Japan: Botulinum Toxin Market Breakdown, by End User
  - 9.1.1.2 China
    - 9.1.1.2.1 Overview
    - 9.1.1.2.2 China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.2.3 China: Botulinum Toxin Market Breakdown, by Product
    - 9.1.1.2.4 China: Botulinum Toxin Market Breakdown, by Application
    - 9.1.1.2.4.1 China: Botulinum Toxin Market Breakdown, by Medical
    - 9.1.1.2.4.2 China: Botulinum Toxin Market Breakdown, by Aesthetic
    - 9.1.1.2.5 China: Botulinum Toxin Market Breakdown, by End User
  - 9.1.1.3 India: Botulinum Toxin Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.1 Overview
    - 9.1.1.3.2 India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.3.3 India: Botulinum Toxin Market Breakdown, by Product
    - 9.1.1.3.4 India: Botulinum Toxin Market Breakdown, by Application
    - 9.1.1.3.4.1 India: Botulinum Toxin Market Breakdown, by Medical
    - 9.1.1.3.4.2 India: Botulinum Toxin Market Breakdown, by Aesthetic
    - 9.1.1.3.5 India: Botulinum Toxin Market Breakdown, by End User
  - 9.1.1.4 South Korea
    - 9.1.1.4.1 Overview
    - 9.1.1.4.2 South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.4.3 South Korea: Botulinum Toxin Market Breakdown, by Product
    - 9.1.1.4.4 South Korea: Botulinum Toxin Market Breakdown, by Application
    - 9.1.1.4.4.1 South Korea: Botulinum Toxin Market Breakdown, by Medical
    - 9.1.1.4.4.2 South Korea: Botulinum Toxin Market Breakdown, by Aesthetic
    - 9.1.1.4.5 South Korea: Botulinum Toxin Market Breakdown, by End User
  - 9.1.1.5 Australia
    - 9.1.1.5.1 Overview
    - 9.1.1.5.2 Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.5.3 Australia: Botulinum Toxin Market Breakdown, by Product
    - 9.1.1.5.4 Australia: Botulinum Toxin Market Breakdown, by Application
    - 9.1.1.5.4.1 Australia: Botulinum Toxin Market Breakdown, by Medical
    - 9.1.1.5.4.2 Australia: Botulinum Toxin Market Breakdown, by Aesthetic
    - 9.1.1.5.5 Australia: Botulinum Toxin Market Breakdown, by End User
  - 9.1.1.6 Rest of Asia Pacific
    - 9.1.1.6.1 Overview
    - 9.1.1.6.2 Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.6.3 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by Product
    - 9.1.1.6.4 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by Application
    - 9.1.1.6.4.1 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by Medical
    - 9.1.1.6.4.2 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by Aesthetic
    - 9.1.1.6.5 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by End User

10. Company Profiles

10.1 Merz Pharma GmbH & Co KGaA
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 AbbVie Inc
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Ipsen SA
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Evolus Inc
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Medytox Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Galderma SA
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Hugel Inc
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Lanzhou Institute of Biological Products Co Ltd
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Botulinum Toxin Market Segmentation
Table 2. Asia Pacific Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
Table 3. Asia Pacific Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
Table 4. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 5. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 6. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
Table 7. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
Table 8. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 9. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 10. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 11. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
Table 12. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
Table 13. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 14. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 15. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 16. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
Table 17. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
Table 18. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 19. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 20. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 21. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
Table 22. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
Table 23. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 24. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 25. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 26. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
Table 27. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
Table 28. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 29. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 30. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 31. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
Table 32. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
Table 33. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. Glossary of Terms

List Of Figures

Figure 1. Botulinum Toxin Market Segmentation, by Country
Figure 2. Botulinum Toxin Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Botulinum Toxin Market Revenue (US$ Million), 2021-2031
Figure 5. Botulinum Toxin Market Share (%) - by Product (2023 and 2031)
Figure 6. Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Botulinum Toxin Market Share (%) - by Application (2023 and 2031)
Figure 9. Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Botulinum Toxin Market Share (%) - by End User (2023 and 2031)
Figure 12. Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Asia Pacific: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)
Figure 16. Asia Pacific: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 17. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)